Literature DB >> 9021567

Pulmonary artery band migration producing endobronchial obstruction.

R L Parry1, S Gordon, N J Sherman.   

Abstract

Pulmonary artery banding is used in infants to temporarily control excessive pulmonary blood flow. There are reports of band migration including intact bands eroding through the pulmonary artery. The patient presented here had bronchiectasis and eventual destruction of his right middle and lower lobes 5 years after pulmonary artery banding and subsequent definitive cardiac corrective surgery. After undergoing a right middle and lower lobectomy, recurring postoperative respiratory distress prompted repeat bronchoscopy where the original pulmonary artery band was identified and removed. It is hypothesized that this band migrated through the pulmonary artery and into the tracheobronchial tree where it led to obstruction and subsequent destruction of the right middle and lower lobes. Awareness of this potential complication is important for pediatric surgeons who so often care for patients with a past history of cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021567     DOI: 10.1016/s0022-3468(97)90091-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Morphological and functional characterization of leech circulating blood cells: role in immunity and neural repair.

Authors:  Céline Boidin-Wichlacz; David Vergote; Christian Slomianny; Nathalie Jouy; Michel Salzet; Aurélie Tasiemski
Journal:  Cell Mol Life Sci       Date:  2011-12-11       Impact factor: 9.261

2.  Hemoptysis in a teenager with congenital heart disease.

Authors:  Nisreen Rumman; Stuart Berger; Aparna Rao
Journal:  Pediatr Cardiol       Date:  2010-10-24       Impact factor: 1.655

Review 3.  Application of a complication screening method to congenital heart surgery admissions: a preliminary report.

Authors:  Oscar J Benavidez; Kimberlee Gauvreau; Emile Bacha; Pedro Del Nido; Kathy J Jenkins
Journal:  Pediatr Cardiol       Date:  2007-10-03       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.